Daito Pharmaceutical Co.,Ltd.
JP ˙ TSE ˙ JP3486150000
1.356,00 ¥ ↓ -15,00 (-1,09%)
2026-10-19
AKTIENPREIS
SecurityJP:4577 / Daito Pharmaceutical Co.,Ltd.
InstitutionVGTSX - Vanguard Total International Stock Index Fund Investor Shares
Latest Disclosed Ownership373,382 shares
Latest Disclosed Value $ 2,993,740
VGTSX - Vanguard Total International Stock Index Fund Investor Shares ownership in 4577 / Daito Pharmaceutical Co.,Ltd.

On June 26, 2026 - VGTSX - Vanguard Total International Stock Index Fund Investor Shares filed a NPORT-P form disclosing ownership of 373,382 shares of Daito Pharmaceutical Co.,Ltd. (JP:4577) valued at $470,834,702 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 31, 2026 disclosing 373,382 shares of Daito Pharmaceutical Co.,Ltd.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $506,305,992 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP DAITO PHARMA EC JP3486150000 373,382 0 0.00 2,994 -7.14 0.0005
2026-03-31 2026-01-31 NP DAITO PHARMA EC JP3486150000 373,382 0 0.00 3,223 7.04 0.0005
2025-12-23 2025-10-31 NP DAITO PHARMA EC JP3486150000 373,382 0 0.00 3,012 0.90 0.0005
2025-09-25 2025-07-31 NP DAITO PHARMA EC JP3486150000 373,382 169,341 82.99 2,984 0.34 0.0006
2025-06-30 2025-04-30 NP DAITO PHARMA EC JP3486150000 204,041 0 0.00 2,974 9.14 0.0006
2025-03-31 2025-01-31 NP DAITO PHARMA EC JP3486150000 204,041 4,400 2.20 2,725 -6.58 0.0006
2024-12-27 2024-10-31 NP DAITO PHARMA EC JP3486150000 199,641 14,900 8.07 2,917 -1.15 0.0007
2024-09-27 2024-07-31 NP DAITO PHARMA EC JP3486150000 184,741 25,400 15.94 2,951 16.00 0.0007
2024-06-27 2024-04-30 NP DAITO PHARMA EC JP3486150000 159,341 0 0.00 2,544 19.61 0.0006
2024-04-01 2024-01-31 NP DAITO PHARMA EC JP3486150000 159,341 0 0.00 2,127 4.52 0.0005
2023-12-28 2023-10-31 NP DAITO PHARMA EC JP3486150000 159,341 14,485 10.00 2,036 -14.64 0.0006
2023-09-29 2023-07-31 NP DAITO PHARMA EC JP3486150000 144,856 0 0.00 2,385 -11.57 0.0006
2023-06-29 2023-04-30 NP DAITO PHARMA EC JP3486150000 144,856 0 0.00 2,696 -8.08 0.0007
2023-03-31 2023-01-31 NP DAITO PHARMA EC JP3486150000 144,856 0 0.00 2,933 17.74 0.0008
2022-12-28 2022-10-31 NP DAITO PHARMA EC JP3486150000 144,856 16,200 12.59 2,491 -2.50 0.0008
2022-09-29 2022-07-31 NP DAITO PHARMA EC JP3486150000 128,656 17,300 15.54 2,555 14.73 0.0007
2022-06-29 2022-04-30 NP DAITO PHARMA EC JP3486150000 111,356 0 0.00 2,227 -17.55 0.0006
2022-04-01 2022-01-31 NP DAITO PHARMA EC JP3486150000 111,356 0 0.00 2,701 -13.98 0.0007
2021-12-30 2021-10-31 NP DAITO PHARMA EC JP3486150000 111,356 0 0.00 3,140 -7.07 0.0008
2021-09-29 2021-07-31 NP DAITO PHARMA EC JP3486150000 111,356 -212 -0.19 3,380 -4.52 0.0008
2021-06-29 2021-04-30 NP DAITO PHARMA EC JP3486150000 111,568 -11,100 -9.05 3,540 -18.44 0.0009
2021-04-01 2021-01-31 NP DAITO PHARMA EC JP3486150000 122,668 -18,058 -12.83 4,339 -19.29 0.0011
2020-12-29 2020-10-31 NP DAITO PHARMA EC JP3486150000 140,726 -16,700 -10.61 5,376 15.14 0.0014
2020-09-29 2020-07-31 NP DAITO PHARMA EC JP3486150000 157,426 0 0.00 4,670 -7.87 0.0011
2020-03-31 2020-01-31 NP Daito Pharmaceutical Co. EC JP3486150000 157,426 8,300 5.57 5,068 12.87 0.0012
2019-12-30 2019-10-31 NP Daito Pharmaceutical Co. EC JP3486150000 149,126 149,126 4,491 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.